Cargando…
Association Between Adjuvant Sorafenib and the Prognosis of Patients With Hepatocellular Carcinoma at a High Risk of Recurrence After Radical Resection
BACKGROUND: The use of sorafenib in the adjuvant management of hepatocellular carcinoma (HCC) is controversial. AIM: To analyze the effects of adjuvant sorafenib therapy in patients with HCC at high recurrence risk after radical resection. METHODS: This was a retrospective study of patients who unde...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495215/ https://www.ncbi.nlm.nih.gov/pubmed/34631511 http://dx.doi.org/10.3389/fonc.2021.633033 |